Does Rallies show Form 4 insider transactions for PRE?

Yes. Rallies tracks PRE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PRE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PRE. It does not provide personalized investment advice.

PRE (Prenetics Global Limited Class A Ordinary Share) Stock Analysis - Insider Trades

Prenetics Global Limited Class A Ordinary Share (PRE) is a publicly traded Healthcare sector company. As of May 20, 2026, PRE trades at $15.25 with a market cap of $247.19M and a P/E ratio of 0.00. PRE moved +4.28% today. Year to date, PRE is -7.38%; over the trailing twelve months it is +110.89%. Its 52-week range spans $3.09 to $23.63. Analyst consensus is buy with an average price target of $32.50. Rallies surfaces PRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PRE stock inside the company?

Recent PRE insider activity includes Desmet Laurie sold 710, Hanratty Judith sold 2.34K, SAUTTER REMY sold 3.03K, SAUTTER REMY sold 200, and SAUTTER REMY sold 300. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PRE Key Metrics

Key financial metrics for PRE
Metric	Value
Price	$15.25
Market Cap	$247.19M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.70%
52-Week High	$23.63
52-Week Low	$3.09
Volume	64.78K
Avg Volume	0
Revenue (TTM)	$5.39B
Net Income	$74.63M
Gross Margin	14.89%

Recent PRE Insider Trades

Desmet Laurie sold 710 (~$98.77K) on Dec 21, 2015.
Hanratty Judith sold 2.34K (~$325.40K) on Oct 29, 2015.
SAUTTER REMY sold 3.03K (~$419.50K) on Sep 17, 2015.
SAUTTER REMY sold 200 (~$27.69K) on Sep 17, 2015.
SAUTTER REMY sold 300 (~$41.54K) on Sep 17, 2015.

Latest PRE News

Prenetics Raises 2026 IM8 Guidance to $210M, Adds Jay Shetty as Shareholder — May 20, 2026
Prenetics Global Q1 Revenue Jumps 333% to $36M; IMA Guidance Raised to $210M — May 14, 2026
Prenetics Raises Full-Year IM8 Guidance to $210M After Q1 Revenue Soars 334% — May 14, 2026
Prenetics’ IM8 Secures Multi-Year Inter Miami CF Deal with Equity Stake — May 7, 2026
Prenetics’ IM8 Partnership to Aid 400,000 Mothers and Children First Year — Apr 14, 2026

PRE Analyst Consensus

2 analysts cover PRE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $32.50.

Common questions about PRE

Who is trading PRE stock inside the company?: Recent PRE insider activity includes Desmet Laurie sold 710, Hanratty Judith sold 2.34K, SAUTTER REMY sold 3.03K, SAUTTER REMY sold 200, and SAUTTER REMY sold 300. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PRE?: Yes. Rallies tracks PRE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PRE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PRE. It does not provide personalized investment advice.